These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 8968650)

  • 61. Preliminary trial of clonidine treatment in two patients suffering from chronic schizophrenia.
    Elizur A; Levy A; Lahav M; Blum I
    Commun Psychopharmacol; 1980; 4(6):507-17. PubMed ID: 6117398
    [No Abstract]   [Full Text] [Related]  

  • 62. Information processing and maintenance dose requirements in schizophrenia.
    Marder SR; Asarnow RF; Van Putten T
    Psychopharmacol Bull; 1988; 24(2):247-50. PubMed ID: 2905506
    [No Abstract]   [Full Text] [Related]  

  • 63. What are the therapeutic needs in schizophrenia and how are they satisfied by new antipsychotics?
    Kane JM
    Int Clin Psychopharmacol; 1997 May; 12 Suppl 2():S3-6. PubMed ID: 9218161
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Assessing and measuring nonresponse in schizophrenia.
    Kane JM
    J Clin Psychiatry; 2012 Jan; 73(1):e04. PubMed ID: 22316583
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Report on an open investigation on bromperidol, a neuroleptic of the butyrophenone series].
    Fleischhauer J
    Int Pharmacopsychiatry; 1978; 13 Suppl 1():30-7. PubMed ID: 35476
    [No Abstract]   [Full Text] [Related]  

  • 66. [Pilot study on oxaflumazine, a new piperazinated phenothiazine].
    Villeneuve A; Dogan K; Lachance R; Drolet A
    Int J Clin Pharmacol; 1972 Aug; 6(3):246-55. PubMed ID: 4405378
    [No Abstract]   [Full Text] [Related]  

  • 67. [Negative vs. positive therapy expectations and compliance vs. noncompliance].
    Linden M
    Psychiatr Prax; 1987 Jul; 14(4):132-6. PubMed ID: 2887002
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Serum cholesterol and treatment-resistance in schizophrenia.
    Boston PF; Dursun SM; Zafar R; Reveley MA
    Biol Psychiatry; 1996 Sep; 40(6):542-3. PubMed ID: 8879475
    [No Abstract]   [Full Text] [Related]  

  • 69. Pharmacological treatment of schizophrenia.
    Leucht S; Heres S; Kissling W; Davis JM
    Fortschr Neurol Psychiatr; 2013 May; 81(5):e1-13. PubMed ID: 23702802
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nifedipine in neuroleptic-refractory schizophrenia.
    Kramer MS; DeMaria P; Morrow R; DiJohnson C; Sheves P
    J Clin Psychopharmacol; 1987 Jun; 7(3):195-6. PubMed ID: 2885346
    [No Abstract]   [Full Text] [Related]  

  • 71. [Education groups in neuroleptic treatment of schizophrenic patients].
    Gaillard P; Degiovanni A; Parrot F
    Ann Med Psychol (Paris); 1993 Apr; 151(4):340-2. PubMed ID: 7904433
    [No Abstract]   [Full Text] [Related]  

  • 72. Understanding schizophrenia: the impact of novel antipsychotics.
    Remington G
    Can J Psychiatry; 1995 Sep; 40(7 Suppl 2):S29-32. PubMed ID: 8564914
    [No Abstract]   [Full Text] [Related]  

  • 73. Specific indications for different classes of phenothiazines.
    Hollister LE; Overall JE; Kimbell I; Pokorny A
    Arch Gen Psychiatry; 1974 Jan; 30(1):94-9. PubMed ID: 4148660
    [No Abstract]   [Full Text] [Related]  

  • 74. Enhancing compliance in schizophrenic patients by weekly dosing with levothyroxine sodium.
    Walch TJ
    J Clin Psychiatry; 1994 Dec; 55(12):543. PubMed ID: 7814350
    [No Abstract]   [Full Text] [Related]  

  • 75. Drug treatment for schizophrenia.
    Tylee A
    Practitioner; 1995 Feb; 239(1547):116-9. PubMed ID: 7708614
    [No Abstract]   [Full Text] [Related]  

  • 76. Untreated psychosis and long-term outcome in schizophrenia.
    Waddington JL; Scully PJ
    Schizophr Bull; 1998; 24(1):34-5. PubMed ID: 9502545
    [No Abstract]   [Full Text] [Related]  

  • 77. Change in "overinclusive" thinking of schizophrenic patients is related to plasma phenothiazine concentration.
    Phillipson OT; Baker J; Williams M
    Adv Biochem Psychopharmacol; 1980; 24():591-7. PubMed ID: 6105805
    [No Abstract]   [Full Text] [Related]  

  • 78. Understanding schizophrenia.
    Rigby P; Alexander J
    Nurs Stand; 2008 Mar 19-25; 22(28):49-56; quiz 58, 60. PubMed ID: 18429458
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical symptomatology and drug compliance in schizophrenic patients.
    Bartkó G; Herczeg I; Zádor G
    Acta Psychiatr Scand; 1988 Jan; 77(1):74-6. PubMed ID: 2894746
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characteristics of patients selected for treatment on a schizophrenia research unit.
    Schreiber JL; Breier A; Pickar D
    Hosp Community Psychiatry; 1990 Apr; 41(4):441-3. PubMed ID: 1970550
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.